GENERAL CATALOGUE
LASSBio-2052
HY-161617 · 50 mg
MedChemExpress · Cat: HY-161617
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/lassbio-2052.htmlCatalog No: HY-161617
CAS No: 2549160-15-6
Category: Apoptosis
Pack Size: 50 mg
Brand: MedChemExpress
Description
LASSBio-2052 is a derivative of N-acylhydrazone with antitumor activity against hepatocellular carcinoma HCC . LASSBio-2052 inhibits HCC cells HepG2 and Hep3B, with IC50 of 18 and 41 ?M. LASSBio-2052 arrests the cell cycle at G2/M phase, through downregulation of FOXM1. LASSBio-2052 induces apoptosis in HCC cells.
More from MedChemExpress
2-Bromohexadecanoic acid
HY-111770
Apoptosis
Uridine 5'-monophosphate-15N2
HY-101981S
Apoptosis
AZD-5991
HY-101533
Apoptosis
HDAC-IN-37
HY-146750
Apoptosis
Anti-inflammatory agent 47
HY-155568
Apoptosis
YLT205
HY-117515
Apoptosis
pan-HER-IN-2
HY-144677
Apoptosis
HDAC-IN-84
HY-170379
Apoptosis